A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy

Overview of attention for article published in Gynecologic Oncology, April 2013

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 review on a research highlight platform.

This research output was recommended by a member of Faculty Opinions.

This page shows the most recent research highlights that mention this research output.

Click here to find out how to access more activity.